Regeneron (REGN) wins $400M in damages as jury finds Amgen (AMGN) violated antitrust laws by promoting its heart drug Repatha ...

This was the stock's second consecutive day of gains.

Replimune Group shares fell 28% on heavy volume with no news, despite a promising July 2025 PDUFA date for RP1 in advanced ...

DZ Bank has significantly reduced its holdings in Regeneron Pharmaceuticals, offloading 74.4% of its shares in Q4. Despite ...

To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches ...

The strategy’s performance closely follows the ups and downs of the US stock market, since it is always fully invested. All else equal, this strategy should outperform its peers that hold cash ...

Fidelity Mega Cap Stock Fund earns an Above Average Process Pillar rating. The most important driver of the rating is the fund's strong long-term risk-adjusted performance. This can be seen in its ...

international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock. Fortinet ( NASDAQ:FTNT ) First Quarter 2025 ...

AT&T Inc. Dep. Pfd. (Rep. 1/1000th 4.75% Pfd. Series C) 0.58% AT&T Inc. Dep. Pfd. (Rep. 1/1000th 5% Perp. Pfd. Series A) 0.40% ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.